Ayşegül Üner

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer”.

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer

Cancer Research(2024)10.1158/0008-5472.can-23-2812

N/A

1.1DataRank · unranked

28 citations

Özge Saatci, Nathaniel Oberholtzer, Meral Üner, Özge Akbulut, Metin Çetįn +10 more

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

Cell Death and Disease(2024)10.1038/s41419-024-06814-3

N/A

0.804DataRank · unranked

31 citations

Rashedul Alam, Kim‐Tuyen Huynh‐Dam, Aynur Işık, Meral Üner, Nevin Belder +17 more

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Nature Communications(2020)10.1038/s41467-020-16199-4

N/A

0DataRank · unranked

370 citations

Aysegül Kaymak, Umar Raza, Pelin G. Ersan, Özge Akbulut, Carolyn E. Banister +18 more

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

Cell Death and Differentiation(2023)10.1038/s41418-023-01140-1

N/A

0DataRank · unranked

35 citations

Özge Akbulut, Metin Çetįn, Vitali Sikirzhytski, Meral Üner, Deniz Lengerli +8 more

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Nature Communications(2023)10.1038/s41467-023-42736-y

N/A

0DataRank · unranked

13 citations

Metin Çetįn, Meral Üner, Ünal Metin Tokat, Ioulia Chatzistamou, Pelin G. Ersan +8 more

Targeting LINC00152 activates cAMP/Ca 2+ /ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.05.565697

N/A

0DataRank · unranked

2 citations

R. T. M. Alam, Kim‐Tuyen Huynh‐Dam, Aynur Işık, Meral Üner, Nevin Belder +15 more